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Abstract: Pregnant women in Asia, the Middle East, Africa and Latin America are at risk of vitamin
D deficiency (VDD) and prevalence throughout these regions are among the highest, globally.
Maternal VDD has been associated with increased risk of a number of adverse maternal and neonatal
health outcomes, yet research from developing countries is limited. We assessed the associations of
maternal VDD during pregnancy with adverse health outcomes by synthesizing the literature from
observational studies conducted in developing countries. Six electronic databases were searched for
English-language studies published between 2000 and 2017. Thirteen studies from seven countries
were included in the review. Prevalence of VDD ranged from 51.3% to 100%. Six studies assessed
both maternal and neonatal outcomes, four studies assessed only maternal outcomes and three
studies assessed only neonatal outcomes. Ten studies showed at least one significant association
between VDD and adverse maternal and/or neonatal health outcomes including pre-eclampsia
(n = 3), gestational diabetes mellitus (n = 1), postpartum depression (n = 1), emergency cesarean
section delivery (n = 1), low birth weight babies (n = 4), small for gestational age (n = 2), stunting
(n = 1). However most of these studies (n = 6) also showed no association with multiple health
outcomes. Vitamin D assessment methods, criteria applied to define VDD, season and trimester in
which studies were conducted varied considerably across studies. In conclusion, this study highlights
the need to improve maternal vitamin D status in developing countries in an effort to support best
maternal and child health outcomes across these regions. Future research should focus on more
unified approaches to vitamin D assessment and preventative approaches that may be embedded
into already existing antenatal care settings.
Keywords: vitamin D; pregnancy; obstetric; maternal; neonatal; developing countries; pre-eclampsia;
gestational diabetes mellitus; low birth weight; small for gestational age
1. Introduction
Vitamin D deficiency (VDD), defined as 25 hydroxyvitamin D concentration (25OHD) below
50 nmol/L (20 ng/mL) [1] is recognized as a global health problem, affecting around one billion
people across all ethnicities and age groups worldwide [2]. Low serum 25OHD has been described as
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completely preventable [3], and is considered an important public health priority, given the adverse
health outcomes associated with its deficiency [4].
Vitamin D is produced endogenously following exposure of the skin to ultraviolet (UV) radiation,
with only small proportions being derived from exogeneous dietary sources [5]. Yet, despite sufficient
and stable sunny conditions across equatorial countries [2,6,7], studies have reported high prevalence
of VDD in pregnant and lactating women [6,8] and infants [6,9,10] in such areas, ranging from 26–95%
during pregnancy [11]. Women throughout Asia [12,13], the Middle East and Africa [13] have been
consistently regarded as “high risk” for deficiency, with particularly high prevalence being observed
throughout these continents.
Vitamin D is a pleiotropic pro-hormone [14,15] that functions through an endocrine (regulation of
calcium absorption) and autocrine (facilitation of gene expression) mechanism [14,15]. Once ingested or
produced by the body via sunlight exposure, vitamin D is transported to the liver for hydroxylation to
25(OH)D, the main circulating form of vitamin D, and then to the kidney where the biologically active
hormone form of vitamin D 1,25(OH)2D is produced. Maternal 25OHD can freely cross the human
placenta whereby the placenta expresses vitamin D receptors (VDR) and the enzyme CYP27B1 that
can convert 25(OH)D to its biologically active form 1,25-dihydroxyvitamin D (1,25OH2D). While it is
beyond the scope of this review to provide detail regarding the plausible biological pathways through
which vitamin D could influence neonatal health, during pregnancy, VDD has been associated with
increased risk of a number of adverse maternal and child health outcomes. These include an increased
risk of pre-eclampsia and gestational diabetes mellitus (GDM), increased production of maternal
inflammatory cytokines [16], insulin resistance [17], primary caesarean section [17] and more recently,
with high maternal body mass index (BMI) [18] and symptoms of postpartum depression [19]. For the
offspring, increased risk of preterm birth [16], small for gestational age (SGA) babies [16], neonatal
hypocalcemia [17], rickets in infancy [20], recurrent wheeze, asthma [17] and increased adiposity
during childhood [18] have been documented outcomes associated with maternal VDD.
It is well established that women with dark skin pigmentation are at an increased risk of VDD [21],
yet a range of lifestyle factors have also been identified as key contributors to obtaining sufficient
vitamin D [22]. Increased time spent indoors and away from sunlight, liberal sunscreen use (and/or
sun avoidance) secondary to skin cancer concern in some areas of the world, adoption of covered
clothing due to religious, cultural or aesthetic reasons and global environmental pollution are all
factors implicated in the increased prevalence of VDD [22]. Moreover, women living in low-income,
developing countries are often unable to meet micronutrient demands of pregnancy due to a chronically
poor diet [23]. Inadequate access to dietary sources of vitamin D such as oily fish and eggs or having a
vegetarian diet, which is common in some regions throughout Asia, make attaining sufficient vitamin
D via food sources increasingly difficult. Women with one or more of these lifestyle risk factors could
be considered particularly vulnerable to VDD, which may impact upon their health and the health of
their offspring.
For women in developing countries specifically, although there has been recent research which
has reported on the prevalence of VDD in such populations and in some cases on pregnancy
complications [24–27], there has been no published systematic review assessing associations of maternal
VDD with maternal and/or neonatal outcomes. In order to assist women to achieve optimal vitamin D
levels during pregnancy via culturally suitable strategies, it is necessary to first investigate the impact
of deficiency on health outcomes in “high risk” populations throughout the developing world. The aim
of this review was to assess the association of maternal VDD with adverse maternal and neonatal
outcomes by synthesizing the literature from studies conducted with women in developing countries.
While not an overarching aim of the review, biological and lifestyle factors associated with increased
risk of deficiency were also summarized when they were assessed.
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2. Materials and Methods
2.1. Study Criteria
Observational studies which assessed associations between maternal VDD during pregnancy with
maternal and/or neonatal complications or adverse health outcomes were reviewed. Studies which
included either short term (during pregnancy, e.g., maternal pre-eclampsia) and/or long term
(following pregnancy, e.g., maternal postpartum depression) health complications which were
associated with VDD were eligible for inclusion. Further, studies which included well-established
and medically diagnosed pregnancy and/or neonatal health complications (e.g., GDM, pre-eclampsia,
caesarean section delivery, postpartum depression, low birth weight (LBW), SGA, rickets,
osteoporosis etc.) as opposed to reported symptoms and/or sole risk factors for these conditions (or
related morbidity), as study outcomes were eligible.
Cross-sectional, longitudinal, cohort and ecological studies were eligible for inclusion while
intervention studies were excluded as they would not allow for a true assessment of the impact of
VDD on maternal and child health, in the absence of a specific treatment of the deficiency. We elected
to exclude case-control studies as they are inherently susceptible to selection bias, incidence rates
of maternal VDD could not be obtained via such studies and actual relative risk is unable to be
determined [28]. They are also suitable particularly to assessment of rare diseases or outcomes [29] and
as such were eliminated in the assessment of common pregnancy complications such as those included
in the review. Non-human studies and those which did not include pregnancy and/or neonatal
complications as either a primary or secondary outcome were excluded. There were no limitations
placed on age due to known high rates of teenage/adolescent pregnancies across developing countries
specifically [30], or timing of pregnancy and neonatal complications (e.g., trimesters, or diseases
tracking into infancy or childhood).
2.2. Search Strategy
A comprehensive search of the literature was conducted in July 2017 using the EBSCO host
platform and included the MEDLINE, CINAHL, Health Source: Nursing/Academic Edition and
Global Health databases. A separate search using the EMBASE platform was also conducted at the
same time. Studies were limited by year (2000–2017) to English only and to human studies across
all databases. The Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA)
guidelines were adhered to and formed the basis for methodology relevant to this review. A list
of “developing countries” for searching purposes was derived from that previously defined by the
Australian Minister of Foreign Affairs of the Department of Foreign Affairs and Trade (DFAT) for the
Overseas Aid Gift Deduction, established in 1997 [31]. The search strategy combined the keywords
Pregnan* OR Gestation* OR “Vitamin D” OR “serum 25-hydroxyvitamin D” OR “serum 25OHD” OR
25OHD OR “serum 25-hydroxyvitamin D (25OHD)” OR “hypovitaminosis D” OR cholecalciferol OR
Deficien* OR Insufficien* OR “Developing Countr*” OR Brunei OR Cambodia OR “East Timor” OR
“Timor Leste” OR Indonesia OR Lao OR Malaysia OR Myanmar OR Burma OR Phillippine OR Filipino
OR Thailand OR Vietnam OR Turkmenistan OR Uzbekistan OR Maldives OR Mongolia OR Nepal OR
Pakistan OR “Sri Lanka” OR Tajikistan OR Kazakhstan OR Korea OR Kyrgyzstan OR China OR India
OR Afghanistan OR Bangladesh OR Bhutan OR Albania OR Armenia OR Azerbaijan OR Belarus OR
“Bosnia & Herzegovina” OR Georgia OR Kosovo OR Macedonia OR Moldova OR Montenegro OR
Serbia OR Turkey OR Ukraine OR Algeria OR Egypt OR Libya OR Morocco OR Tunisia OR Angola OR
Benin OR Botswana OR “Burkina Faso” OR Burundi OR Cameroon OR “Cabo Verde” OR “Central
African Republic” OR Chad OR Comoros OR Congo OR “Cote d’Ivoire” OR “Ivory Coast” OR Djibouti
OR “Equatorial Guinea” OR Eritrea OR Ethiopia OR Gabon OR Gambia OR Ghana OR Guinea OR
“Guinea-Bissau” OR Kenya OR Lesotho OR Liberia OR Madagascar OR Malawi OR Mali OR Mauritania
OR Mauritius OR Mozambique OR Namibia OR Niger OR Nigeria OR Rwanda OR “St. Helena” OR
“Sao Tome & Principe” OR Senegal OR Seychelles OR “Sierra Leone” OR Somalia OR “South Africa” OR
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“South Sudan” OR Sudan OR Swaziland OR Tanzania OR Togo OR Uganda OR Zambia OR Zimbabwe
OR “Antigua & Barbuda” OR Belize OR “Costa Rica” OR Cuba OR Dominica OR “Dominican Republic”
OR “El Salvador” OR Grenada OR Guatemala OR Haiti OR Honduras OR Jamaica OR Mexico OR
Montserrat OR Nicaragua OR Panama OR “St. Lucia” OR “St. Vincent and the Grenadines” OR
Argentina OR Bolivia OR Brazil OR Chile OR Colombia OR Ecuador OR Guyana OR Paraguay OR
Peru OR Suriname OR Uruguay OR Venezuela OR Iran OR Iraq OR Jordan OR Lebanon OR “Syrian
Arab Republic” OR “West Bank and Gaza Strip” OR Yemen OR “Cook Islands” OR Fiji OR Kiribati OR
“Marshall Islands” OR Micronesia OR Nauru OR Niue OR Palau OR “Papua New Guinea” OR Samoa
OR “Solomon Islands” OR Tokelau OR Tonga OR Tuvalu OR Vanuatu OR “Wallis & Futuna”.
2.3. Data Extraction
A data extraction template adapted from a previously published systematic review conducted by
two of the authors [32] guided data extraction. Two researchers (PvP and JW) independently extracted
the data addressing criteria consisting of study design and methodology, sample characteristics,
approaches to measurement of vitamin D, criteria and prevalence of deficiency, health outcomes and
biological or lifestyle characteristics associated with increased risk of deficiency. Any differences in the
extraction and interpretation of data were resolved by discussion between the researchers.
2.4. Quality Assessment
Studies were assessed for quality using the McMaster University quality assessment tool [33].
As per the protocol, for each study, a rating scale assessed selection bias, study design, confounders,
data collection and withdrawals and dropouts, with a rating of either weak, moderate or strong
allocated to each component. Where detail of a component was missing a weak rating was given.
An overall quality rating was given as either weak (two or more weak component ratings), moderate
(less than four strong ratings and one weak rating) or strong (four strong ratings with no weak ratings).
Two researchers (JW and EM) independently assessed study quality and any discrepancies in overall
ratings were resolved by discussion.
3. Results
3.1. Study Selection
The EBSCO host platform search including MEDLINE, CINAHL, Health Source:
Nursing/Academic Edition and Global Health retrieved 628 papers and the EMBASE platform search
retrieved 669 papers. These were imported into an EndNote library and all duplicate studies were
removed (n = 475), leaving a total of 822 papers. The title and abstract of each were reviewed by PvP
and JW to assess eligibility and where insufficient detail was available in the title or abstract, full
papers were assessed for inclusion. After reviewing the title and abstract of each paper, 26 studies were
retained and the full-text papers were reviewed. Cross checking of titles and abstracts of excluded
studies to ensure reliability of the screening process was conducted by JW. No additional papers
were included via this process. Both PvP and JW independently assessed all full-text papers for
inclusion eligibility. Level of agreement between the two researchers was high. Minor differences
between researchers regarding the inclusion of papers were resolved by discussion. The bibliographies
of papers for inclusion were hand searched but no further papers were included in the review via
this process. A summary of the study selection process is presented in Figure 1. In total, 13 studies
were included in the systematic review. A summary of each study included is presented in Table 1.
For consistency all units of vitamin D measurement were converted to nmol/L (from ng/mL or
otherwise) for study comparisons. Overall, ten out of the 13 studies included showed at least one
significant association between VDD and adverse maternal and/or neonatal health outcomes.
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Figure 1. Flow diagram of included studies.
3.2. Setting and Participants
Overall the 13 studies represented data from seven different countries within Asia [24,26,34–36],
the Middle East [25,37–40] and Africa [6,27]. Two studies were conducted in India [24,34], three
in China [26,35,36], three in Turkey [37,38,41], two in Iran [25,40] and one in each of Pakistan [42],
Kenya [6] and Nigeria [27]. Seven studies were conducted in the inpatient setting within large maternity
hospitals [6,24–27,38,39] and four studies involved women who were recruited as outpatients,
attending antenatal clinic bookings [34,37,40,41]. One study included women recruited through
both of these settings [36] and the study conducted by Chen et al. assessed a sub sample of a large
population-based birth cohort study in China [35]. Mean age of women across studies ranged from
22.5 years [6] to 31.3 years [27]. The number of women recruited ranged from 63 [6] to 3658 [35] and
stage of gestation varied across studies ranging from early pregnancy at 13 weeks [37] to 39 weeks [38].
Eleven out of the 13 studies reported the trimesters in which women took part in the study and
subsequently had their corresponding vitamin D levels assessed. These ranged from one study in the
first trimester [37], two studies in the second trimester [40,41], two studies in both the second and third
trimesters [6,36], four studies in just the third trimester [26,34,38,39] and two studies assessed women
across all three trimesters of their pregnancy [27,35].
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Table 1. Description of included studies.
Study Design Recruitment Sample Serum Vitamin DMeasurement
Criteria for Vitamin D Deficiency
and Reported Prevalence Outcomes Risk Factors
Ajmani et al.,
2016 India [24]
Prospective
cohort
Approached/screened: not reported
Enrolled: not reported
Complete data: n = 200 burka-clad
women
Setting: antenatal clinic and
inpatients in antenatal ward at
Kasturba Hospital, Delhi
Season: all (year-long)
Age: mean 24.8 years
Demographics: 64.5%
multigravida, 44% dark
complexion, 36% low SES, 64%
illiterate, 2.5% graduate level
educated
Trimester: not reported
Exclusion criteria: non-burka
clad, age <18 years or >40 years,
history of liver/renal disease,
osteoporosis or rheumatoid
arthritis, antitubercular or
antiepileptic treatment in last
6 months, taking vitamin D
supplements
ELISA
Criteria *:
Deficiency < 50 nmol/L
Inadequacy 50–75 nmol/L
Adequate > 75 nmol/L
Prevalence of deficiency:
Deficient n = 75 (37.5%)
Inadequate n = 78 (39%)
Adequate n = 47 (23.5%)
Maternal: 7.5% women diagnosed with
pre-eclampsia, significant correlation
between VDD and pre-eclampsia (p = 0.001)
Neonatal: 9.5% LBW babies, significant
correlation between VDD and LBW
(p = 0.0001)
No correlation: VDD and GDM, LSCS, bony
abnormality, Apgar score, premature birth or
NICU admission
Dark skin
complexion, limited
outdoor activity, low
dairy intake, low
fish intake (p < 0.05)
Ates et al.,
2016 Turkey [37]
Prospective
cohort
Approached/screened: n = 286
Enrolled: n = 266 (93%)
Complete data: n = 229 (86%)
Setting: first antenatal appointment
at outpatient clinic of Obstetrics and
Gynecology, Bezmialem Vakif
University, Istanbul
Season: 48.9% summer
(May–October), 51.1% winter
(November–April)
Age: mean 29.5 years
Demographics: 64.5%
primigravida, mean BMI
25.3 kg/m2, 61.3% covered dress,
63.1% multivitamin use, 6.6%
smoking, 46.9% ≥ 9 years
education
Trimester: first
Exclusion criteria: thyroid,
parathyroid or adrenal disease,
hepatic or renal failure, metabolic
bone disease, medication
affecting vitamin D metabolism,
multiple pregnancy, taking
vitamin D supplements
LC-MS/MS
Criteria *:
Severe deficiency < 25 nmol/L
Mod deficiency 25–47.5 nmol/L
Mild deficiency 50–72.5 nmol/L
Adequate > 75 nmol/L
Prevalence of deficiency:
Severe n = 105 (45.9%)
Mod n = 83 (36.2%)
Mild n = 31 (13.5%)
Adequate n = 10 (4.4%)
Maternal: 53.8% women with severe VDD
had vaginal delivery, compared with 32.7%
as primary caesarean section (p = 0.018)
No correlation: VDD and GDM,
pre-eclampsia, gestational hypertension,
preterm birth, SGA, intrauterine fetal death,
congenital malformation, birth weight or
Apgar score
Covered dress,
non-multivitamin
use, winter (p < 0.05)
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Table 1. Cont.
Study Design Recruitment Sample Serum Vitamin DMeasurement
Criteria for Vitamin D Deficiency
and Reported Prevalence Outcomes Risk Factors
Aydogmus et al.,
2014 Turkey [38]
Prospective
cohort
Approached/screened: n = 180
Enrolled: n = 152 (84%)
Complete data: n = 148 (97%)
Setting: inpatients at Izmir Katip
Celebi University Ataturk Training
and Research Hospital, Izmir
Season: not reported
Age: mean 24.4 years
Demographics: not reported
Trimester: third
Exclusion criteria: taking vitamin
D supplements, multiparity,
disease affecting vitamin D and
calcium metabolism, medications
for chronic disease
ELISA
Criteria *:
Deficient < 37.5 nmol/L
Insufficient 37.5–72.5 nmol/L
Sufficient > 75 nmol/L
(grouped for analysis
Deficient < 37.5 nmol/L; Other ≥
37.5 nmol/L)
Prevalence of deficiency:
Deficient: n = 66 (44.6%)
Other n = 82 (55.4%)
Maternal: 39.9% women with VDD had poor
pregnancy outcomes compared with 23.2%
of women without VDD (p = 0.001), VDD
increased risk of perinatal complications (OR
4.30; 95% CI 1.85–9.99)
Neonatal: 16.7% SGA neonates born to
mothers with VDD compared with 4.9%
neonates born to mothers without VDD
(p = 0.007), VDD increased risk of SGA (OR
4.5; 95% CI 1.41–15.78); mean birthweight
significantly lower for neonates born to
mothers with VDD (3187.6 ± 495.5 g)
compared with those born to mothers
without VDD (3268.1 ± 477.1 g) (p = 0.02)
No correlation: VDD and mode of delivery,
post maturity, GDM, maternal anemia,
hypertension, pre-eclampsia, cholestasis,
oligohydraminos, fetal distress, still birth,
preterm labor, PPROM, Apgar scores,
prolonged hospitalization, mortality,
NICU admission or macrosomia
No significant
associations
Chen et al.,
2015 China [35]
Prospective
cohort
Approached/screened: n = 4358
(sub-sample of a population-based
cohort study n = 16,766)
Enrolled: n = 3658 (84%)
Complete data: 3658 (100%)
Setting: women recruited to the
larger China-Anhui Birth Cohort
study from six major cities of Anhui
province
Season: all (year-long), 36.7% spring,
22.5% summer, 20.6% autumn, 20.2%
winter
Age: mean 27.5 years
Demographics:
96.0% nulliparous, 45.2% low
income, 75.3% healthy BMI,
16.5% multivitamin use
Trimester: all, 35.1% first, 62.0%
second, 2.9% third
Exclusion criteria: multiple
pregnancy, abortion
RIA
Criteria *:
Deficient < 50 nmol/L
Insufficient 50–74.75 nmol/L
Sufficient ≥ 75 nmol/L
Prevalence of deficiency:
Deficiency
n = 1405 (38.4%)
Insufficiency
n = 1289 (35.2%)
Sufficient
n = 964 (26.4%)
Maternal: not assessed
Neonatal: 16.01% SGA neonates born to
mothers with VDD compared with 5.59%
born to mothers with vitamin D insufficiency
and 2.80% with sufficient vitamin D (p <
0.001); compared to sufficiency, maternal
VDD increased risk of SGA (RR 6.47; 95% CI
4.30–9.75) and insufficiency (RR 2.01; 95% CI
1.28–3.16) (p < 0.001); 4.98% LBW neonates
born to mothers with VDD compared with
1.32% born to mothers with vitamin D
insufficiency and 0.41% with sufficient
vitamin D (p < 0.001); VDD increased risk of
LBW (RR 12.31; 95% CI 4.47–33.89) (p <
0.001).
Adjusted for:
Pre-pregnancy maternal BMI, maternal age,
season and gestational week
Not assessed
Farrant et al.,
2009 India [34]
Prospective
cohort
Approached/screened: n = 1539
Enrolled: n = 830 (54%)
Complete data: n = 674 (81%)
Setting: women attending antenatal
clinic at Holdsworth Memorial
Hospital, Mysore
Season: all (year-long)
Age: mean 23.7 years
Demographics: mean BMI
23.4 kg/m2, women
supplemented at recruitment
(n = 156) with vitamin D as part
of routine management, no
information available at 30 weeks
Trimester: third
Exclusion criteria: not reported
RIA
Criteria:
Hypovitaminosis < 50 nmol/L
Adequate > 50 nmol/L
Prevalence of deficiency:
Hypovitaminosis n = 372 (67%)
Adequate: n = 187 (33%)
No correlation: VDD and GDM,
birthweight, impaired fetal growth
Autumn/winter
(p < 0.05)
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Table 1. Cont.
Study Design Recruitment Sample Serum Vitamin DMeasurement
Criteria for Vitamin D Deficiency
and Reported Prevalence Outcomes Risk Factors
Gbadegesin et al.,
2016 Nigeria [27]
Prospective
cohort
Approached/screened: not reported
Enrolled: n = 461
Complete data: n = 461 (100%)
Setting: maternity unit of the Lagos
State University Teaching Hospital,
Ikeja and women of mixed ethnicity,
social class and religion
Season: all (year-long)
Age: mean 31.3 years
Demographics: mean parity 1.16
Trimester: all
Exclusion criteria: multiple
pregnancy, previous medical
condition (hypertension, renal
disease, diabetes), taking vitamin
D supplements, elevated BP
HPLC
Criteria *:
Deficiency < 50 nmol/L
Insufficiency 52.5–75 nmol/L
Adequate > 75 nmol/L
Prevalence of deficiency:
Deficiency n = 134 (29.0%)
Insufficiency n = 48 (10.4%)
Adequate n = 279 (60.6%)
No correlation: VDD and preeclampsia,
SROM, anemia, GDM, preterm delivery,
mode of delivery, Apgar score or stillbirth
No significant
associations
Gur et al.,
2014 Turkey [41]
Prospective
cohort
Approached/screened: n = 687
Enrolled: n = 208 (30%)
Complete data: n = 189 at 1/52 (91%);
n = 184 at 6/52 (88%); n = 179 at 6/12
(86%)
Setting: women attending routine
antenatal reviews at Sifa University
Bornova Health Research and
Application Hospital, Izmir
Season: summer/autumn
Age: mean 28.5 years
Demographics: mean BMI
26.5 kg/m2, 7.6% women
supplemented with vitamin D ≥
3 days per week and 84.6%
supplemented daily, all women
Caucasian and native Turkish
speaking
Trimester: second
Exclusion criteria: unmarried,
unplanned pregnancy, BMI <
20 or >30 kg/m2, smoker,
diagnosed psychiatric illness,
pre-diagnosed medical condition,
parity > 3, education level <
8 years, multiple birth, employed,
annual income < US $450, fetal
death, complex delivery, newborn
with anomaly, postpartum
bleeding or hysterectomy
ELISA
Criteria *:
Severe deficiency < 25 nmol/L
Mild deficiency
25 nmol/L–50 nmol/L
Normal ≥ 50 nmol/L
Prevalence of deficiency:
Severe: n = 23 (11%)
Mild n = 84 (40.3%)
Normal n = 101 (48.5%)
Maternal: 21.1%, 23.2% and 23.7% women
had PPD at week 1, 6 and 6 months
respectively; significant negative correlation
(r = −0.2, −0.2, −0.3) between vitamin D
levels and Edinburgh Postnatal Depression
Scale (EPDS) score at each of the three time
points; mean vitamin D level was
significantly different between women with
and without PPD at each of the three time
points (p = 0.003, p = 0.004 and p <
0.001 respectively)
Neonatal: not assessed
Not assessed
Hossain et al.,
2010 Pakistan [39] Cross-sectional
Approached: not reported (all
women admitted to the labor suite
for delivery during the study period
were deemed eligible)
RR: not reported
Complete data: n = 75
Setting: delivery at Dow University
of Health Sciences and Civil Hospital,
Karachi
Season: spring
Age: mean 26.0 years
Demographics: mean BMI
27 kg/m2, mean parity 2.2, 26%
covering arms, hands heads, 76%
covering face
Trimester: third
Exclusion criteria: not reported
CI
Criteria *:
Severe deficiency < 25 nmol/L
Mod deficiency 27.5–50 nmol/L
Mild deficiency 52.5–60 nmol/L
Adequate > 60 nmol/L
Prevalence of deficiency:
Severe: n = 34 (45%)
Mod: n = 20 (27%)
Mild: n = 13 (17%)
Adequate: n = 8 (11%)
Maternal: compared with women in the
highest tertile for vitamin D, women in the
lowest tertile and mid-tertile were more
likely to meet criteria for pre-eclampsia and
gestational pre-hypertension (OR 2.28; 95%
CI 0.35–23.28) and (OR 19.27; 95% CI
1.96–188.92 respectively); vitamin D levels
were inversely correlated with maternal
mean arterial pressure (r = 0.029) (p = 0.020)
Neonatal: not assessed in relation to
maternal vitamin D
Adjusted for maternal age, level of exercise,
maternal weight, birthweight and
gestational age
Not assessed
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Table 1. Cont.
Study Design Recruitment Sample Serum Vitamin DMeasurement
Criteria for Vitamin D Deficiency
and Reported Prevalence Outcomes Risk Factors
Maghbooli et al.,
2008 Iran [40] Cross-sectional
Approached/screened: not reported
Enrolled: n = 741
Complete data: n = 579
Setting: referral to five university
hospital clinics of the Tehran
University of Medical Sciences
during the first half of pregnancy
Season: not reported
Age: mean 27.4 years
Demographics: mean BMI
26.4 kg/m2
Trimester: second
Exclusion criteria: prenatal
diabetes
RIA
Criteria:
Severe deficiency < 12.5 nmol/L
Mild deficiency 12.5–24.9 nmol/L
Mod deficiency 25–34.9 nmol/L
Sufficiency > 34.9 nmol/L
Prevalence of deficiency:
Severe n = 201 (27.1%)
Mild n = 118 (15.9%)
Mod n = 344 (46.4%)
Sufficient n = 78 (10.5%)
Maternal: 52% women diagnosed with
GDM, mean vitamin D significantly lower in
women with GDM (16.49 ± 10.44 nmol/L)
compared with non-GDM women (22.97 ±
18.25 nmol/L) (p = 0.009), prevalence of
severe VDD was significantly higher in
women with GDM (44.2%) compared with
non-GDM women (23.5%) (p = 0.011)
Neonatal: not assessed
Not assessed
Pirdehghan et al.,
2016 Iran [25] Cross-sectional
Approached/screened: not reported
Enrolled: not reported
Complete data: n = 200
Setting: admission to hospital
delivery room for natural delivery,
caesarean section or abortion at
Shahid Sadoughi hospital
Season: autumn/spring
Age: mean 26.7 years
Demographics: all women
nulliparous, 48.7%
diploma/university educated,
97.5% housewives, 38.5% women
taking multivitamins containing
vitamin D during pregnancy,
Trimester: not reported
Exclusion criteria: pre-existing
medical conditions (renal or bone
disorders), medication
influencing calcium or vitamin D
metabolism. multiparity
ELISA
Criteria *:
Severe deficiency < 25 nmol/L
Moderate deficiency 25–50 nmol/L
Mild deficiency 52.5–75 nmol/L
Adequate 75–125 nmol/L
Upper normal/toxic > 125 nmol/L
Prevalence of deficiency:
(figures reported in text)
Severe 12.5%
Deficiency 60%
Maternal: mean vitamin D significantly
higher in natural or elective caesarean
section women compared with abortion and
emergency caesarean section women
(p = 0.040); VDD associated with risk of
abortion 3.1 (1.39–6.8) which was higher in
severe deficiency women compared with
VDD women (p = 0.045), mean vitamin D
significantly lower in women with
oligohydramnios or polyhydramnios
complication (13.9 + 9.5 and 20.6 +
10.8 respectively) (p = 0.045)
No correlation: VDD and preeclampsia,
PROM,
GDM, birth weight, birth length, head
circumference or Apgar score
No significant
associations
Song et al.,
2012 China [26] Cross-sectional
Approached/screened: not reported
Enrolled: not reported
Complete data: 70
Setting: delivery at 306 Hospital of
PLA in Beijing from surrounding
communities of the Beijing urban
area
Season: spring
Age: 29.9 (±0.3) years
Demographics:
Mean weight: 73.9 kg, pregravid
range 0–3
Trimester: third
Exclusion criteria: multiparity,
taking calcium and/or vitamin D
supplements, pre-existing
medical conditions (hypertension,
renal disease, pre-gestational
diabetes)
ELISA
Criteria:
Severe deficiency < 25 nmol/L
Mild deficiency 25– < 50 nmol/L
Insufficiency 50– < 75 nmol/L
(21–29 ng/mL)
Sufficiency ≥ 75 nmol/L
(grouped for analysis
Deficient < 25 nmol/L and other ≥
25 nmol/L
Prevalence of deficiency:
Severe n = 38 (54.5%)
Mild n = 25 (35.7%)
Insufficient n = 7 (10.0%)
Sufficient n = 0 (0%)
Maternal: not assessed
Neonatal: significant correlation between
maternal vitamin D and newborn length
(r = 0.247) (p = 0.039);
compared with women who had vitamin D
≥ 25 nmol/L, birth weight (3633.1 g) and
length (51.0 cm) of newborns were
significantly lower in women with vitamin D
< 25 nmol/L (3386 g and 50.2 cm
respectively) (p = 0.015, p = 0.037)
No correlation: VDD or head circumference
Not assessed
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Table 1. Cont.
Study Design Recruitment Sample Serum Vitamin DMeasurement
Criteria for Vitamin D Deficiency
and Reported Prevalence Outcomes Risk Factors
Toko et al.,
2016 Kenya [6] Longitudinal
Approached/screened: n = 99
RR: not reported
Complete data: n = 63 (baseline data
used) (64%)
Setting: women residing within a
10 km radius of Chulaimbo
Sub-district hospital in Kisumu
County
Season: dry season
Age: mean 22.5 years
Demographics: mean BMI
22.9 kg/m2
Trimester: second and third
Exclusion criteria: more than
26 weeks gestation, HIV infected,
residing >10 km from the hospital
ELISA
Criteria:
Deficiency < 50 nmol/L
Insufficiency 50–75 nmol/L
Sufficiency > 75 nmol/L
(grouped for analysis low <
50 nmol/L and adequate ≥
50 nmol/L)
Prevalence of deficiency:
Deficient n = 13 (20.6%)
Insufficient n = 32 (50.8%)
Sufficient n = 19 (28.6%)
Maternal: not assessed
Neonatal: newborns more likely to have
stunted growth at birth when born to
mothers with deficient vitamin D (RR 4.4 (CI
1.0–18.6) (p = 0.04) and more likely to be
born preterm (<37 weeks) (RR 5.4 (CI 1.1,
25.3) (p = 0.03)
Adjusted for: maternal age, gestational age
at delivery and maternal BMI
No correlation: VDD and wasting or BMI
z-score
Not assessed
Xin et al.,
2017 China [36]
Prospective
cohort
Approached/screened: not reported
Enrolled: n = 13,806
Complete data: n = 11,151 (81%)
Setting: routine visit to antenatal care
clinic and delivery at the Wuxi
Maternity and Child Health Hospital
Season: 28.4% winter, 18.5% spring,
22.7% autumn, 30.4% summer
Age: mean 27.3 years
Demographics: 88.9%
nulliparous, 9.2% BMI ≥
25 kg/m2, 96% GA at delivery ≥
37 weeks
Trimester: second and third
Exclusion criteria: taking calcium
and/or vitamin D supplements,
pre-existing medical conditions
(hypertension, renal disease,
pre-gestational diabetes), fetal
anomalies
CI
Criteria:
Deficiency < 50 nmol/L
Sufficiency > 50 nmol/L
Prevalence of deficiency:
Deficient n = 8799 (78.9%)
Sufficient n = 2352 (20.8%)
Maternal: 1.2% pre-eclampsia, significant
difference in incidence of severe
pre-eclampsia in pregnant women with VDD
(<50 nmol/L) (n = 123; 1.4%) compared with
sufficiency (≥50 nmol/L) (n = 16; 0.6%)
(p = 0.002), women with VDD were more at
risk of developing severe pre-eclampsia
compared with women who were vitamin D
sufficient (OR: 3.16; 95% CI: 1.77–5.65)
(p = 0.000)
Adjusted for: pre-pregnancy BMI, maternal
age, parity and season of blood sampling
Neonatal: not assessed
Age ≥ 35 years,
pre-pregnancy BMI
≥ 25 kg/m2,
nulliparity (p < 0.05)
* Vitamin D unit of measurement converted from ng/mL to nmol/L. Abbreviations: VDD—vitamin D deficiency; BMI—Body Mass Index; CI—automated chemiluminescence immunoassay;
ELISA—enzyme-linked immunosorbent assay; GDM—gestational diabetes mellitus; LC-MS/MS—liquid chromatography tandem-mass spectrometer; LSCS—lower segment caesarean
section; NICU—neonatal intensive care unit; OR—odds ratio; PPD—postpartum depression; RIA—radioimmunoassay; SGA—small for gestational age; PROM—premature rupture of
membrane; SROM—spontaneous rupture of membranes.
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3.3. Vitamin D Assessment
Five different methods across studies were used to measure serum 25OHD levels. Six studies used
enzyme-linked immunosorbent assay (ELISA) methods [6,24–26,38,41]. Each study showed one or
more positive association between VDD and maternal and/or neonatal health outcomes. Three studies
utilized radioimmunoassy (RIA) [34,35,40], with two studies showing positive associations between
VDD and maternal GDM [40] and neonatal LBW and SGA [35]. Two studies used automated
chemiluminescence immunoassay (CI) [36,39], both of which assessed maternal outcomes only and
showed positive associations between VDD and maternal pre-eclampsia. One study used liquid
chromatography tandem-mass spectrometry (LC/MS/MS) [37] and one used high-performance liquid
chromatography (HPLC) [27] with both studies showing no significant associations between VDD and
either maternal or neonatal outcomes.
3.4. Vitamin D Deficiency, Criteria and Prevalence
With reference to the criteria used to define VDD and the reference values and cut-point scores
for prevalence, approaches varied widely and were not dependent on the country in which the study
was conducted. Likewise, prevalence of VDD differed widely within studies which employed the
same techniques for assessment of vitamin D. There were varied classifications used to define VDD,
inadequacy or insufficiency. Deficiency was defined as <50 nmol/L [24,27,34,35], <37.5 nmol/L [38]
and as severe/moderate and/or mild in several studies [25,26,37,39–41], with variation as to how each
was classified.
Prevalence of combined deficiency and insufficiency (vs adequacy or sufficiency) ranged from
39.4% [27] to 76.5% [24] depending on the criteria used. Six studies further characterized the severity
of deficiency into mild, moderate or severe [25,26,37,39–41] using a range of different cut-points.
When it was not combined with insufficiency, prevalence of VDD ranged from 51.3% [41] to
100% [26]. Overall the highest prevalence (>80%) were observed in Chinese women (100%) [26],
Turkish women (95.6%) [37], women from Iran (89.4%) [40] and Pakistan (89.0%) [39]. Five studies
showed prevalence of between 70 and 80% among their samples of Indian women [24], Chinese
women [35,36], women from Iran [25] and women in Kenya [6], one study reported a prevalence of
67.0% in India [34] and the two studies conducted in Turkey showed prevalence of VDD between
50 and 60% [37,38]. The study conducted in Nigeria showed the lowest rates of VDD (39.4% when
deficiency was combined with insufficiency and 29.0% deficiency alone) [27]. This study was also the
only study to use HPLC for assessment of vitamin D and showed no significant association between
VDD and maternal or neonatal outcomes. Likewise, there was wide seasonal variation in which studies
were conducted. Six out of the 13 studies were conducted across all seasons or were “yearlong” and
showed VDD prevalence ranging from 39.4% [27] to 95.6% [37]. Two studies with VDD prevalence of
55.4% [38] and 100% [26] did not report the season in which the study was conducted.
3.5. Maternal and Neonatal Outcomes
Ten out of the 13 studies (77%) included in this review showed significant associations between
maternal VDD with either maternal and/or neonatal adverse health outcomes [6,24–26,35,36,38,40–42].
Overall six studies assessed the association of maternal VDD with both maternal and neonatal health
outcomes [24,25,27,34,37,38], four studies assessed maternal outcomes only [36,40–42] and three
studies [6,26,35] assessed only neonatal outcomes. A summary of assessed maternal and neonatal
outcomes is shown in Table 2.
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Table 2. Associations of VDD with reported maternal and neonatal outcomes across studies.
Maternal Outcomes
Study PE GDM Anemia GHTN OHD Mode ofDelivery * Cholestasis PPO PH MMAP PPD PC PROM/SROM
Ajmani et al. (2016)
India [24] + - -
Ates et al. (2016)
Turkey [37] - - - +
Aydogmus et al. (2014)
Turkey [38] - - - - - - - + - + -
Chen et al. (2015)
China [35]
Farrant et al. (2009)
India [34] -
Gbadegesin et al. (2016)
Nigeria [27] - - - - -
Gur et al. (2014)
Turkey [41] +
Hossain et al. (2010)
Pakistan [39] + + +
Maghbooli et al. (2008)
Iran [40] +
Pirdehghan et al. (2016)
Iran [25] - - + -
Song et al. (2012)
China [26]
Toko et al. (2016)
Kenya [6]
Xin et al. (2017)
China [36] +
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Table 2. Cont.
Neonatal Outcomes
Study Macro. Stunted Growth * Preterm Birth W z-Score Still Birth/IFD NICU Admit Apgar Score Post MB HC CM * Birth Weight * Birth Length SGA
Ajmani et al. (2016)
India [24] - - - - +
Ates et al. (2016)
Turkey [37] - - - - - -
Aydogmus et al. (2014)
Turkey [38] - - - - - - + +
Chen et al. (2015)
China [35] + +
Farrant et al. (2009)
India [34] - -
Gbadegesin et al. (2016)
Nigeria [27] - - -
Gur et al. (2014)
Turkey [41]
Hossain et al. (2010)
Pakistan [39]
Maghbooli et al. (2008)
Iran [40]
Pirdehghan et al. (2016)
Iran [25] - - - -
Song et al. (2012)
China [26] - + +
Toko et al. (2016)
Kenya [6] + + -
Xin et al. (2017)
China [36]
Note that +: significant association between VDD and the outcome in question; -: no significant association. When neither + or - is given indicated that outcome was not assessed.
VDD—vitamin D deficiency; PE—pre-eclampsia; GDM—gestational diabetes mellitus; GHTN—gestational hypertension; OHD—oligohydramnios; PROM—premature rupture of
membrane; SROM—spontaneous rupture of membranes; IFD—Intrauterine Fetal Death; NICU—neonatal intensive care unit; HC—head circumference; CM—congenital malformation
SGA—small for gestational age; PH—prolonged hospitalization; Macro—macrosomia; Post MB—post mature birth; MMAP—mean maternal arterial pressure; W z-score—wasting z score;
PPO—poor pregnancy outcomes (grouped by study researchers); PPD—postpartum depression; PC—perinatal complications risk. * Grouped outcomes: Mode of Delivery (includes
vaginal delivery and lower segment caesarean section), Birth weight (includes low birth weight), Congenital Malformation (includes Bony Abnormality), Stunted Growth (includes
Impaired Fetal Growth), Still birth/IFD (includes mortality).
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Maternal VDD was shown to be associated with pre-eclampsia in three out of four studies [24,36,42]
and GDM in one out of seven studies [40]. Associations with pregnancy and perinatal complications
were found by Aydogmus et al. [38] (which was the only study to report grouped adverse maternal
outcomes), postpartum depression in the only study by Gur et al. that assessed it [41] and abortion,
emergency cesarean section delivery, oligohydramnios and polyhydramnios complication in one out
of four studies [25]. Maternal VDD was not associated with premature or spontaneous rupturing of
membranes (PROM and SROM) in two studies [27,38].
Neonatal outcomes adversely associated with maternal VDD were shown in five out of eight
studies [6,24,25,35,38]. Maternal VDD was significantly associated with low birth weight (LBW) in
four out of seven studies [24,26,35,38], small for gestational age (SGA) babies in two out of three
studies [35,38] and stunting (but not wasting or BMI z-score) immediately post-delivery, which was
only assessed as an outcome in the study by Toko et al. [6], and preterm birth in one out of five
studies [6]. Among those outcomes which were not significantly associated with maternal VDD
in any of the studies were Apgar score [24,25,27,37,38], NICU admission [24,38], neonatal death or
stillbirth [27,37,38] or head circumference [25,26].
Each of the three studies that did not show any significant associations between VDD and adverse
outcomes assessed both maternal and neonatal outcomes [27,34,37]. One study was conducted in each
of Turkey [37], India [34] and Nigeria [27] where prevalence of VDD were 95.6%, 67.0% and 39.4%
respectively. All three studies were conducted “yearlong” but recruited women at different stages
of their pregnancies. Two out of the three studies [27,37] used the same criteria (serum 25OHD >
75 nmol/L) to define sufficient vitamin D, however criteria to define deficient vitamin D (e.g., severe,
moderate, mild etc.) differed between the studies.
3.6. Biological and Lifestyle Risk Factors
Seven out of the 13 studies assessed biological and lifestyle factors associated with increased risk of
VDD, as part of their analyses [24,25,27,34,36–38]. In their study conducted in India, Ajmani et al. [24]
found that factors which increased the risk of VDD were dark skin pigmentation, limited dairy and
fish intake as sources of dietary vitamin D and limited outdoor activity. In a separate study in India,
Farrant et al. [34] found that the risk of VDD increased in the autumn and winter months. Likewise, in
Turkey it was reported that the risk of deficiency significantly increased in the winter months and in
women who did not use multivitamins or with skin covering clothing [37]. In China, maternal age
≥35 years, pre-pregnancy BMI ≥25 kg/m2 and nulliparity were found to increase the risk of maternal
VDD [36]. The remaining three studies showed no association between biological and lifestyle risk
factors and maternal VDD [25,27,38].
3.7. Study Quality
A summary of the quality of each study is presented in Table 3. All studies were given weak
global ratings for study quality, defined as two or more weak ratings for individual study components
including selection bias, study design, confounders, blinding, data collection methods and dropouts.
Overall ratings for the 13 studies are presented in Table 4. Data collection methods were strong across
all studies (13/13) while quality of study selection of participants and withdrawals and dropouts were
varied considerably. Study design, blinding and adjustment for confounding variables were rated
weak for the majority of studies (13/13; 11/13; 10/13). Overall, four out of the 13 studies adjusted
for some confounding variables in their analyses [6,35,36,42]. All four studies adjusted for maternal
age and either maternal pre-pregnancy BMI or maternal weight, three studies adjusted for gestational
age [6,35,42], two studies adjusted for season [35,36] and one study adjusted for maternal physical
activity [42].
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Table 3. Summary of study quality assessment ratings for included studies.
Study Selection Bias Study Design Cofounders Blinding Data Collection Method Withdrawals and Dropouts Global Rating
Ajmani et al. (2016)
India [24] 3 3 3 3 1 3 Weak
Ates et al. (2016)
Turkey [37] 1 3 3 3 1 1 Weak
Aydogmus et al. (2015)
Turkey [38] 2 3 3 3 1 1 Weak
Chen et al. (2015)
China [35] 1 3 1 3 1 1 Weak
Farrant et al. (2009)
India [34] 2 3 3 3 1 2 Weak
Gbadegesin et al. (2016)
Nigeria [27] 3 3 3 3 1 3 Weak
Gur et al. (2014)
Turkey [41] 3 3 3 2 1 1 Weak
Hossain et al. (2010)
Pakistan [39] 3 3 3 3 1 3 Weak
Maghbooli et al. (2008)
Iran [40] 2 3 3 3 1 3 Weak
Pirdehghan et al. (2016)
Iran [25] 3 3 3 2 1 3 Weak
Song et al. (2012)
China [26] 3 3 3 3 1 3 Weak
Toko et al. (2016)
Kenya [6] 3 3 1 3 1 3 Weak
Xin et al. (2017)
China [36] 2 3 1 3 1 1 Weak
1: Strong; 2: Moderate; 3: Weak.
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Table 4. Summary of global ratings for study quality.
Quality Rating
Quality Component Strong (n) Moderate (n) Weak (n)
Selection bias 2/13 4/13 7/13
Study design 0/13 0/13 13/13
Confounders 3/13 0/13 10/13
Blinding 0/13 2/13 11/13
Data collection methods 13/13 0/13 0/13
Withdrawal and dropout 5/13 1/13 7/13
Global rating 0/13 0/13 13/13
1: Strong; 2: Moderate; 3: Weak. Global weak quality: two or more weak component ratings; moderate quality: less
than four strong and one weak component ratings, high quality: four strong and no weak component ratings.
4. Discussion
This systematic review is the first to summarize the available literature of observational studies
on the impact of maternal VDD on adverse health outcomes for the mother and neonate, in developing
countries. It is also the first systematic review to focus solely on this issue in low-income regions.
We identified 13 studies that met the inclusion criteria, highlighting the paucity of research assessing
this issue among “high risk” women throughout these regions. However, consistent with previous
literature on maternal vitamin D status in other regions [43], reported prevalence rates of maternal
VDD in this review from studies conducted across Asia, the Middle East and Africa were high, between
70–80% and as high as 100% in the one study conducted in China [26]. Notwithstanding the limited
available data, the majority of these studies also showed that maternal VDD was associated with at
least one maternal pregnancy complication and/or with complications related to neonatal growth.
Given the 13 included studies in this review were conducted across several countries and multiple
continents, this suggests that VDD and its associated adverse health outcomes for women and children,
are widespread. These findings are perhaps not surprising given that among developing countries,
malnutrition and the burden of disease is high in relation to reproductive, maternal, newborn and child
health [44]. Global data have consistently reported associations between maternal VDD with serious
pregnancy complications including pre-eclampsia, GDM, infection and cesarean section delivery [45],
which in part are consistent with findings from this review. Importantly, GDM increases the risk of
pre-eclampsia developing later in pregnancy [46], which along with infection, are independently
associated with increased risk of maternal mortality [47]. Moreover, hypertensive disorders in
pregnancy are among the major causes of maternal death in developing countries, as reported by the
World Health Organization (WHO) [48]. Despite rates of maternal mortality having declined over the
last 10 years in some regions of Asia and Northern Africa [49], compared to in developed countries,
maternal mortality rates for women in developing countries are 14-fold higher [50]. Factors which
indirectly increase the risk of maternal mortality such as maternal VDD should be a consideration
for public health initiatives, focused on improving adequacy and standards of antenatal healthcare in
developing countries, to best support the health and survival rates of women during their pregnancies.
It is well-established that neonatal vitamin D status can be determined directly by measuring
circulating maternal 25(OH)D [3] and there is evidence to support and association between maternal
25OHD levels with adverse health outcomes. In this review, we identified five studies that reported
significant associations between maternal VDD and LBW, SGA and stunting. Globally it is estimated
that 23% of children under 5 years are stunted [51] and 15% of newborns have LBW [51] and combined,
Africa and Asia account for almost 100% of the global burden of stunting [51]. Reductions in the
prevalence of childhood stunting is a key target of the United Nations Sustainable Development Goals
for 2030 [50] and addressing the issue of maternal and neonatal VDD should be a key component of
action across developing countries in assisting achieving these global targets.
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Children in developing countries born to breastfeeding mothers who are vitamin D deficient
face a double burden in relation to risk of impaired growth and related morbidity. Despite exclusive
breastfeeding in the first six months of life being recommended as the primary source of newborn
feeding and nutrition [52], breast milk is a poor source of vitamin D [53,54]. Moreover, infants born
with VDD, and/or who are exclusively breastfed with limited sun exposure, are at increased risk
of rickets in the first year of life [55,56]. While supplementing breastfeeding with vitamin D can
effectively assist in managing infant VDD, this practice occurs predominately in only high-income
countries [57,58]. Public health strategies to ensure children attain sufficient vitamin D are therefore
key to supporting a healthy start to life, healthy growth trajectories and a reducing the risk of stunting
and infant rickets.
Ten of the 13 studies included in this review found significant associations between maternal
VDD and adverse health outcomes, yet many of these also found that VDD did not impact specific
maternal and/or neonatal complications. In the wider literature including developed countries,
methodological flaws have been identified as contributing to the inconsistent associations [59,60].
Similarly, in this review there was significant variation and heterogeneity in methodological approaches
employed across studies with noticeable difference in the methods used to assess serum 25OHD
concentrations, the stage during pregnancy at which it was measured, the criteria used to define
deficiency or insufficiency and the trimester of pregnancy in which women took part in the studies.
Seasonal differences and length of the study period also differed markedly. Such differences make
drawing generalizable conclusions from both individual studies and the combined data difficult.
Moreover, while ratings for study components varied in their quality within and across studies, overall
study quality was poor. Just four of the studies adjusted for important confounders, known to impact
maternal vitamin D and the various health outcomes assessed. Given there are well-established
risk factors for VDD including increased BMI [1], adjustment for maternal pre-pregnancy BMI for
example, and other confounders, should be ensured in future, along with similar studies assessing
associations of VDD with pregnancy-related health outcomes. Further, investigation and assessment
of the adoption of more unified approaches to vitamin D measurement, which are practically suitable
across developing countries, should be a consideration for future research [61]. This would benefit
planning, design and development of appropriate RCTs and culturally suitable preventative public
health strategies targeting maternal VDD and associated health outcomes.
An important consideration in design of potential cohort studies and interventions in resource
poor countries is the cost associated with assessing vitamin D status, and the approach used to
measure serum 25OHD levels. Currently there are a number of different methods used to quantify
serum 25OHD which has led to considerable variation in circulating levels across different assays
and hampered attempts to develop evidence-based criteria for defining VDD, insufficiency and
sufficiency. At present the LC-MS/MS-based assays are considered the reference method for measuring
25OHD [62] but are unlikely to be routinely available in many developing countries. To overcome issues
related to different 25OHD assays, the vitamin D Standardization Program (VDSP) was developed
in 2010 by the National Institutes of Health Office of Dietary Supplements, the Centers for Disease
Control and Prevention (CDC), the National Institutes of Standards and Technology (NIST) and
Ghent University, with the aim to standardize the laboratory measurement of serum 25OHD [63].
It is, therefore, recommended that all future studies ensure that serum 25OHD levels are assessed at
certified laboratories to the standard reference method developed by NIST and Ghent University [63].
Currently the WHO does not recommend routine screening or supplementation of vitamin D
during pregnancy [64], on the premise that there are a lack of high-quality evidence from RCTs
providing sufficient rationale and safety for doing so. While there have been limited interventions to
date which have targeted the improvement of pregnancy outcomes in relation to VDD in developing
countries, of those available, most have largely focused on supplementation programs and reported
mixed results [13,65]. Alongside supplementation, lifestyle factors and cultural differences should be
considered when planning future interventions in low-income settings. While not an overarching aim
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of this systematic review, some studies did assess factors associated with maternal VDD. Among these,
infrequent outdoor activity or wearing covered clothing for cultural or religious purposes (thereby
reducing sunlight exposure), limited intake of dietary sources of vitamin D, and being overweight or
obese pre-pregnancy were found to be associated with and increased risk of low maternal vitamin
D status. Results from other studies have confirmed that these factors are consistent predictors of
VDD [22,66]. Thus, it is likely that the combination of supplementation and food fortification where
appropriate, with lifestyle modification (e.g., safe sun exposure) will provide the best approaches to
attaining sufficient vitamin D [22]. Relief of poverty and an improved food supply will assist the
long-term solution to this key public health issue.
In order to design and implement successful intervention strategies focused on improving
maternal vitamin D status, the structure of antenatal healthcare systems across developing countries
and the resources and services available to women during pregnancy must be thoroughly understood
and carefully considered. While all studies in this review were conducted within large maternity
hospitals, obstetric departments or outpatient clinics, many women in resource-poor countries do
not have access to such antenatal services, making opportunity for assessment of vitamin D and
intervention during pregnancy particularly challenging. Understanding available models of care
throughout remote regions is key to maximizing health promotion opportunities. From a public health
perspective, women in these areas should be considered equally to those with better access to more
sophisticated obstetric and antenatal services, as they are likely to comprise a large proportion of the
vitamin D deficient population. Moreover, the preconception period may be a more viable window of
opportunity in which to approach this public health issue, by reducing the number of women entering
pregnancy with VDD. Future research might explore the preconception period as a preferred time in
which to intervene and focus on preventative lifestyle approaches aimed at adolescents and young
women, prior to pregnancy.
A limitation of this review was the exclusion of a meta-analysis to combine the results of
individual studies. A meta-analysis would enable improving the estimates of the effect size of
observed associations, thereby strengthening the conclusions and inferences drawn from the data.
However, the wide methodological variation and heterogeneity in methods used to assess vitamin D
and classify deficiency across studies did not allow for pooling of results. Notwithstanding, this review
was the first to synthesize the literature from developing countries specifically, assessing associations
of VDD with pregnancy and neonatal complications. This has been a key step in further understanding
where future work might be directed, in an effort to improve maternal and child health outcomes in
regions where adequate nutrition support services for women during pregnancy are currently limited
or lacking.
5. Conclusions
Pregnant women and neonates throughout the developing world represent a population group
highly susceptible to VDD and associated adverse health outcomes. This review showed that VDD
during pregnancy is a widespread issue that can adversely affect the health of both women and
children in developing countries. However, current methods to assess VDD differ widely and a more
unified approach would assist informing the development of suitable approaches to tackling this issue.
Addressing the impact of maternal and neonatal VDD through high-quality, rigorous and culturally
suitable research, is key to informing well-designed RCTs targeting this issue. Future research should
focus on strategies which include biological and lifestyle factors and preventative approaches that may
be embedded into already existing antenatal care settings.
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